Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Whatever else comes of the California Stem Cell Research and Cures Initiative—a medical-miracle panacea or a multibillion-dollar biomedical boondoggle—an ad windfall seems a sure thing.
Sources said proponents of the controversial ballot initiative are preparing to spend $20 million to persuade voters to fund embryonic stem-cell research in defiance of President Bush’s restrictions. Backers have raised millions and hired political-advertising firm Winner & Mandabach in Santa Monica, which boasts a 90 percent win record in 130 ballot measures.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in